SlideShare a Scribd company logo
GRAND ROUND
HYPOTHYROIDISM
Moderator: Samir Abdi M.D (Internist)
Presenter: Abdirisak Jacda M.D (R1 IM)
8/18/2023
Summary
 Hx 20 yrs. old woman with known history of recurrent ascites
 CC.. Worsened body swelling last 2 months
 HPI she was having recurrent ascites body swelling for last 2 years but
worsened last two 2months the swelling spread from abdomen to
extremities then lastly to her face,
 ROS
 respiratory SOB orthopnea Cough
 Neuro headache dizziness and
 Cardiac palpitation anasarca
 GU freq, urgency, burning, dysuria with flank pain
 GI epigastric pain nausea constipation
 General fatigue loss of appetite but no fever or night sweet
Summary
 Past obhx two previous NSVD with later one with PPH
 Pmhx two paracentesis one therapeutic and one diagnostic
 Fmhx no similar case
 Social hx:- near baki district
 Drug hx frusemide 40mg od po Paracetamol 500mg po PRN
Phsyicals
 Vitals BP 120/75 P. 117 O2 stat 96% T 36.5 RR 26
 Day 2 vitals
 BP 140/90 P. 96 O2stat 88% T 37.4 RR 22
RBG 207 FBS 124
 Generally, young aged woman looking sick with profound
anasarca
 HEENT, severe pallor on congictiva nails and palms
 neck, painless diffuse goiter mobile with swallowing
 Cardiac:- unremarkable
 Lungs:- orthopnea in day one bilateral basilar crackles with
dullnes on percussion
 Abdomen non-tender, distended due to gravidarum. Have also
shifting dullnes with active bowel sounds
 Neuro GCS of 15/15
 Periphery bilateral biting edema
Date Before admission Day 1 on admission Day 6 on admission
HGB 8.6 7.7 9.1
MCV 89 86 87
PLT 361 Normal Normal doen to rule out
preecalpsia
Cr 1.2 0.8 0.6
BUN 49 38 32
UA
WBC
LE
Protein
Serum
albumi
n
Numerous
+++
++++
20g/L or 2mg/dL
TSH 0.54 Recheck 0.48
T3 0.5
T4 37.5
HbsAg Positive
Blood grouping and cross match done
Revealing
ORH-ve
X-ray
 Bilateral lower lobe small pleural effusion.
What is your DDX
Assessments
1. UTI
2. Hypothyroidism
3. AKI
4. Nephrotic syndrome
5. Chronic HBV infection
PLAN
• Two Units of blood given
superheema 1 ampule BID
• Augmentin 625mg BID
• Tramadol 50mg IM PRN
• Omeprazole 20mg po od
• Levothyroxine 100mg po od
• Dexamethasone 6mg IM BID
Ddx ?????
1. Nephrotic syndrome
2. Preeclampsia
3. Hypothyroidism
For nephrotic syndrome
 Protein loss from kidney
 3-4 gram per dipstick
 Anasarca
 Hypoalbuminemia
Against
Hypothyroid sx
NEPHROTIC GNs
 less inflammation (proliferation) than the nephritic GNs
 “nephrotic” urine:
 see less hematuria, more proteinuria
 azotemia less common, or at least less rapid
 hypertension not as common
NEPHROTIC SYNDROME
Is a syndrome, not a disease
 collection of symptoms and signs due to a common pathology
Can be caused by a variety of diseases
Must look for the specific disease
DEFINITION
Syndrome consisting of the following:
 proteinuria > 3.5 grams/24 hrs
 hypoalbuminemia
 hyperlipidemia and lipiduria
 peripheral edema
MECHANISM
glomerular abnormality  “nephrotic” range
proteinuria is initial insult
 generally > 3.5 grams/24 hrs
hypoalbuminemia
HYPOALBUMINEMIA
 due to  losses in urine
 liver attempts to compensate by  albumin synthesis (up to 50-
60%)
probably in response to  plasma oncotic pressure
 general correlation between urine losses and serum levels
MECHANISM
glomerular abnormality  “nephrotic” range
proteinuria is initial insult
 generally > 3.5 grams/24 hrs
hypoalbuminemia
hyperlipidemia/lipiduria
HYPERLIPIDEMIA
 see  triglycerides, VLDL, LDL, Lp(a) in serum
 see  lipid in urine in form of:
free fat droplets
fatty casts
oval fat bodies
HYPERLIPIDEMIA
 vascular risk likely the same as for non-
nephrotics
 nephrotic pts may have 5.5x greater risk for MI
 HMG CoA reductase inhibitors (“statins”)
are drugs of choice
MECHANISM
glomerular abnormality  “nephrotic” range
proteinuria is initial insult
generally > 3.5 grams/24 hrs
hyperlipidemia/lipiduria
hypoalbuminemia
peripheral edema
(+ renal salt retention)
 Glomerulopathy
 Primary
 Secondary
 some glomerulopathy
 can present as more than one syndrome at different times
The Spectrum of Glomerular
Pathology
The Nephritic-Nephrotic Spectrum
 a clinical picture anywhere on a spectrum with
pure nephritic and pure nephrotic syndromes
at the extremes
Glomerular Disease:
Pathogenesis
 Genetic mutations
 Infection
 Toxin exposure
 Autoimmunity
 Atherosclerosis
 Hypertension
 Emboli
 Thrombosis
 Diabetes mellitus
Spectrum of glomerular diseases
EDEMA
HEART LIVER KIDNEY CAP LEAK
urinalysis
nephrotic nephritic
MCD
MGN
FSGS
DMN
IgAN
IgAN
SLE
antiGBM
IC
ANCA
(quantitate proteinuria)
LYMPH/VEINS
OTHER COMPLICATIONS
 progression to ESRF
 EDEMA
 infection
 hypercoagulation
 risk of complication correlates with degree of proteinuria
 reduction of proteinuria leads to reduction in risk
 if proteinuria cannot be reduced, then risk must be addressed
hyperlipidemia
NEPHROTIC SYNDROME
Minimal Change
Disease Membranous
Glomerulonephropathy
Focal Segmental
Glomerulosclerosis
Diabetic Nephropathy Amyloidosis
NAMES
Minimal Change Disease
Membranous GN
FSGS
EPIDEMIOLOGY
Minimal Change Disease = kids
FSGS = everyone
Membranous = adults
0 yrs 65 yrs
100%
0%
PATHOGENESIS
MCD and FSGS
 T cells produce abnormal cytokine that leads to
glomerular epithelial cell damage
 retraction of podocytes due to ?interaction with anchoring
proteins
 b-dystroglycan
 a3-b1 integrin
Membranous
 due to immune complex deposition
PATHOGENESIS
Causes
 most commonly idiopathic (“primary”)
 90% of cases
 may be secondary to:
 drugs..(NSAIDs, lithium, gold)
 malignancy
 infections..(HIV, hepatitis B+C)
PRESENTATION
Symptoms
 usually present with
edema
 facial, lower limb,
arms/hands
 often quite abrupt
with MCD
 otherwise well. .don’t look
sick
 may complain of foamy
Signs
 pitting edema in
dependent areas
 usually not much else
INVESTIGATIONS
Urine
 dipstick strongly (+) for protein, little
blood
 usually more than 3.0g/24 hr on
collection
 microscopy shows lipiduria
 free fat droplets
 oval fat bodies
 fatty casts
Blood
 hypoalbuminemia
 hyperlipidemia
 creatinine usually normal or mildly
elevated
DIAGNOSIS
 cannot differentiate between various nephrotic
GNs from history/exam alone
 firm diagnosis depends on renal biopsy
PROGNOSIS
MCD MGN FSGS
Persistent
proteinuria
60-70% remit or
stabilize
persistent
proteinuria
Renal failure
usually NOT a
concern
30% chance of
progression to ESRF
over 15 yrs
5 yr renal
survival 60-90%
10 yr renal
survival 30-50%
TREATMENT
MCD
 corticosteroids the drug of choice
 in children, biopsy usually not done straight to steroids with nephrotic
syndrome
 in adults, biopsy usually done for diagnosis first
 1 mg/kg daily usual dose
 may require 4-8 wks. before response is seen
TREATMENT
MGN
 all pts should receive angiotensin converting
enzyme inhibitors (ACEi) or angiotensin receptor
blocking agents (ARBs)
 2nd line treatment reserved for those pts at risk of
progression
 elevated creatinine at presentation
 normal GFR after 3 yrs is good sign
 proteinuria > 10g/24 hrs
 esp if > 6 months duration
TREATMENT
FSGS
 corticosteroids the drug of choice
 2 mg/kg alternate days is usual dose
 may require 3 months before response is seen (often 6-9 months for full
response)
 50% remission rate
TREATMENT
3 main 2nd line agents include
 corticosteroids
 variable results when used alone
 best used in combination with another agent
 cyclophosphamide
 probably more effective than steroids alone but
higher toxicity
 cyclosporine
 may also be useful as first line…usually less toxicity
MGN and FSGS
Recommendations
 asymptomatic, protein < 3.5 g/day  ACEi/ARB
 asymptomatic, protein > 3.5 g/day and no risk factors 
ACEi/ARB
 symptomatic, protein > 3.5 g/day  ACEi/ARB + 2nd line
agent
 asymptomatic, protein > 3.5 g/day + risk factors 
ACEi/ARB + 2nd line agent
TREATMENT
MCD MGN FSGS
corticosteroids
(prednisone)  30% 
2ND line agents rarely 30% 50%
plasmapheresis 10%
(post
transplant)
TAKE HOME MESSAGE
 some glomerular diseases present with a
“nephrotic” picture
 proteinuria, edema, hyperlipidemia,
hypoalbuminemia
 thrombosis, infection
 these diseases may progress to ESRF but
usually very slowly
 renal Bx is usually the only way to make a
firm diagnosis
Hypothyroidism
For hypothyroidism
 Sx
 edema constipation fatigue
 Signs
 loss of outer 1/3 of eyebrows
 Congestion abdominal
distension shifting dullnes,
bibasilar carckles bitting
edema till knees
 Labs low T3/T4 and low TSH
Against
 Labs
 proteinuria
 Hypoalbuminemia
Classification of Hypothyroidism
www.drsarma.in
50
A. Primary
1. Enlarged Thyroid
- Hashimoto’s (65%)
- Iodine Deficiency
(25%)
- Drug-induced
(Lithium)
- Dysharmonogenesis
2. Normal Thyroid
- Spontaneous Atrophic
Primary contd..
3. Post Ablative
- Permanent
- Transient
- Sub-clinical
4. Congenital
B. Secondary / Central
Pituitary/ hypothalamic
IDD
www.drsarma.in
51
Clinical considerations
www.drsarma.in
52
www.drsarma.in
53
Disease Burden
1. 5% of the general population are Sub-clinically Hypothyroid
2. 15 % of all women > 65 yrs. are hypothyroid
3. Detecting sub-clinical hypothyroidism in pregnancy is highly essential
– order for TSH and FT4 routinely in all pregnant women at the
beginning of each trimester
4. All persons aged above 60 years – Order for TSH
www.drsarma.in
54
Multi system effects - Hypothyroidism
General
•Lethargy, Somnalence
•Weight gain, Goitre
•Cold Intolerence
Cardiovascular
•Bradycardia, Angina
•CHF, Pericardial Effusion
•HyperlipIdemia,
Xanthelsma
Haematological
Iron def. Anaemia,
Normo cytic /chromic
Anaemia
Reproductive system
•Infertility, Menorrhagia
•Impotence, Inc. Prolactin
Neuromuscular
•Aches and pains
•Muscle stiffness
•Carpel tunnel syndrome
•Deafness, Hoarseness
•Cerebellar ataxia
•Delayed DTR, Myotonia
•Depression, Psychosis
Gastro-intestinal
•Constipation, Ileus,
Ascites
Dermatological
•Dry flaky skin and hair
•Myxoedema, Malar
flushes
•Vitiligo, Carotenimia,
www.drsarma.in
55
Clinical Signs of Hypothyroidism
 Coarse Hair; Dry cool and pale skin
 Goitre (not in all cases), Hoarseness of voice
 Non-pitting oedema (myxoedema)
 Puffiness of eyes and face
 Delayed relaxation of DTR
 Slow hoarse speech and slow movements
 Thinning of lateral 1/3 of eye brows
 Bradycardia, pericardial effusion
What the mind knows the eyes see !!
www.drsarma.in
56
 Psychiatric patients
 Elderly women / men
 Patients of OSA
 Hypercholesterolemia
 Lithium, Amiodarone
 Postpartum women
 Other Autoimmune disease
 Rx. Grave’s Ophthalmopathy
 Family H/o thyroid disease
 Neck irradiation therapy
 Previous Rx for thyrotoxicosis
 Autoimmune Thyroiditis
Order for TSH alone as a screen
Clinical Photographs
www.drsarma.in
57
Congenital Hypothyroidism
www.drsarma.in
58
www.drsarma.in
59
www.drsarma.in
60
Endemic Goiter
www.drsarma.in
61
www.drsarma.in
62
Urine Iodine Conc. < 50 µg/L
Myxedema
www.drsarma.in
63
Myxedema
www.drsarma.in
64
Macroglossia
www.drsarma.in
65
www.drsarma.in
66
Massive Pericardial Effusion in Hypo
20.2.98
www.drsarma.in
67
Clearing of Pericardial Effusion with Rx.
26.7.98
www.drsarma.in
68
Reappearance of Pericardial Effusion
after treatment is discontinued
14.9.99
Hormone replacement
www.drsarma.in
69
Many Causes, One Treatment
www.drsarma.in
70
 Normalize TSH level regardless of cause of hypothyroidism
 Once daily dosing with Levothyroxine sodium (1.6µg/kg/day) this
comes to 100 mcg per day
 Monitor TSH level at 6 to 8 weeks, after initiation of therapy or
dosage change
www.drsarma.in
71
• Treatment of choice is levothyroxin
• Branded thyroxine recommended
• No divided doses - illogical
• Not recommended for use :
 Desiccated thyroid extract
 Combination of thyroid hormones
 T3 replacement except in Myxedema coma
Many Causes, One Treatment
www.drsarma.in
72
 Age (in elderly start with half dose)
 Severity and duration of hypothyroidism (↑ dose)
 Weight (0.5µg/kg/day ↑ upto 3.0µg/kg/day)
 Malabsorption (requires ↑ dose)
 Concomitant drug therapy (only on empty stomach)
 Pregnancy ( 25% ↑ in dose), safe in lactating mother
 Presence of cardiac disease (start alternate day Rx)
Dosage Adjustments
www.drsarma.in
73
 Goal : normalize TSH level – 25, 50 and 100 mcg tablets avail.
 Starting dose for healthy patients < 50 years at 1.0 µg/kg/day
 Starting dose for healthy patients > 50 years should be < 50 µg/day. Dose ↑
by 25 µg, if needed, at 6 to 8 weeks intervals.
 Starting dose for patients with heart disease should be 12.5 to 25 µg/day and
increase by 12.5 to 25 µg/day, if needed, at 6 to 8 weeks intervals
Start Low and Go Slow
www.drsarma.in
74
How the patient improves
 Feels better in 2 – 3 weeks
 Reduction in weight is the first improvement
???????????????????
 Facial puffiness then starts coming down
 Skin changes, hair changes take long time to regress
 TSH starts showing decrements from the high values
 TSH returns to normal eventually
75
The Commandments
76
The Commandments
 Highly suspect
hypothyroidism
 Growth and pubertal delay
 Unexplained depression
 TSH is the test in Hypothy.
 TSH, FT4 to confirm Dx.
 Nine square magic
 Test cord blood for TSH
 All obese patients TSH a must
 For all pregnant -test TSH,
FT4
 Postmenopausal 15%
Hypothy
 Start low and go slow
 Use Levothyroxine only
 Always on empty stomach
 Thyroxine - avoid empirical
use
www.drsarma.in
77
• Case Report
• A 60years old male patient presented with symptoms of
insidious onset, painless, progressive abdominal
distension since 2 months and progressive swelling of
both lower limbs since 1 month.
• He also had constipation and progressive hoarseness
of voice for 2 months.
• He had no history of chest pain, shortness of breath,
orthopnea, paroxysmal nocturnal dyspnea, jaundice,
abdominal pain, hematemesis, melena, urinary symptoms,
anorexia or weight loss.
• He was a chronic smoker for last 25 years and non-
alcoholic.
www.drsarma.in
78
• Examination revealed mild periorbital and facial puffiness along
with bilateral pitting pedal edema.
• His skin was dry and coarse.
• Neurological examination revealed delayed relaxation of ankle
jerks.
• The patient was afebrile with a pulse rate of 75/min, blood pressure
130/80 mm of Hg and elevated jugular venous pressure.
• On cardiopulmonary examination there was muffled heart sounds
with absent breath sounds.
• Chest radiograph showed massive cardiomegaly with bilateral
pleural effusion.
• Ultrasonography abdomen showed moderate ascites and computed
tomography chest and abdomen revealed massive pericardial
effusion, bilateral pleural effusion and moderate ascites.
www.drsarma.in
79
• Electrocardiogram showed low voltage QRS complexes .
• 2D Echocardiogram done subsequently showed a large
circumferential echo free space consistent with massive pericardial
effusion and evidence of cardiac tamponade (diastolic collapse of
right atrium and right ventricle free wall) with preserved left
ventricular systolic function, ejection fraction 55%.
• Viral serology for both hepatitis B and C were negative,
• UGI endoscopy and colour doppler of abdomen were done to
rule out portal hypertension and both were normal.
www.drsarma.in
80
 Ascitic fluid study showed total cells of 100/ cumm with 98%
lymphocytes, high protein (3.24 gm%) and high serum ascitic
albumin gradient (SAAG - 1.91) and normal adenosine
deaminase level (ADA - 6.8 U/L) .
 Pleural fluid examination showed total cells of 200 / cumm
with 90% lymphocytes, high protein (3 . 97 gm%), normal
sugar and normal ADA level (8.1 U/L).
 Cytology of both the fluids were negative for malignancy.
 In view of cardiac tamponade, pericardiocentesis was done with
aspiration of about 1500 ml straw colour fluid.
 Analysis of fluid showed total cells of 10 /cumm with high protein
(5.3 gm%), normal ADA level (8.3 U/L), and cytology revealed
mainly lymphoid and degenerated cells but no malignant
cells.
 Culture of the pericardial fluid was negative for bacteria and acid
www.drsarma.in
81
 Thyroid function tests showed TSH 137.8 mIU/ml (normal
range 0.4 – 4), free T4 0.45 ng/dl (normal range 0.89
 – 1.76), and free T3 0.63 pg/ml (normal range 0.92 – 2.78).
 Ultrasonography revealed atrophic changes in both thyroid
lobes. TPO antibody was negative.
 Subsequent hospital course was uncomplicated and he was
discharged with gradually escalating dose of levothyroxine
from 50 to 100 microgram daily.
 On 4 weeks follow up he was in good health and had
abatement of ascites, pleural effusion and tissue edema
and only minimal pericardial effusion left.
 His TSH was 30.1m IU/ ml and he continued on a
maintenance dose of 100 microgram with regular follow up.
www.drsarma.in
82
 The recent studies, however, conclude that PE is extremely
infrequent in hypothyroidism, with an incidence of 3% to 6%.
 The mainstay of treatment for thyroid PE is simple thyroxine
replacement, except in those patients w i t h pericardial
tamponade or impending tamponade, this condition mandates
urgent pericardiocentesis.
 Pleural effusion per se due to hypothyroidism is rare and
requires careful exclusion of other associated conditions.
 Effusions solely due to hypothyroidism have borderline
characteristics between exudates and transudates and show
little evidence of inflammation.
www.drsarma.in
83
 In conclusion hypothyroidism can have rare modes of
presentations
 .
 It can present with either isolated effusion or in
combination of multiple body cavity effusions along with
tissue edema.
 High index of clinical suspicion is required to diagnose
such cases.
 The treatment is simple and gratifying with almost
complete regression of findings after thyroid hormone
pre-eclampsia
 Summary brief summary
 And ddx with treatment and referral to obstetrician of maternity
ward
For pre-eclampsia
 Proteinuria
 Generalized edema
 Hypo-albuminemia
Against
Goiter
Normotensive
Normal liver enzymes
Normal platelet count

More Related Content

Similar to grand round 2.pptx

Nephrotic.pptx
Nephrotic.pptxNephrotic.pptx
Nephrotic.pptx
NikkyFauzany
 
Pancreatitis scm
Pancreatitis scmPancreatitis scm
Pancreatitis scm
arnab ghosh
 
23 renal disease
23 renal disease23 renal disease
23 renal diseaseinternalmed
 
Major Case Presentation Final Version
Major Case Presentation Final VersionMajor Case Presentation Final Version
Major Case Presentation Final Version
Mmorshed217
 
Chronic renal Disease\failure (CKD)
Chronic renal Disease\failure (CKD)Chronic renal Disease\failure (CKD)
Chronic renal Disease\failure (CKD)
Dr.mujahid Abdallah
 
Adrenal insufficiency
Adrenal insufficiencyAdrenal insufficiency
Adrenal insufficiencyAhad Lodhi
 
Management of Chronic Kidney Disorder (CKD)
Management of Chronic Kidney Disorder (CKD)Management of Chronic Kidney Disorder (CKD)
Management of Chronic Kidney Disorder (CKD)
Sharanya Rajan
 
1. Nephrotic syndrome 01.04.15 lecture.pptx
1. Nephrotic syndrome 01.04.15 lecture.pptx1. Nephrotic syndrome 01.04.15 lecture.pptx
1. Nephrotic syndrome 01.04.15 lecture.pptx
Ivwananjisikombe1
 
Moeez
Moeez Moeez
Moeez
Moeez Butt
 
Vasculitis
VasculitisVasculitis
Vasculitis
drangelosmith
 
Cushing syndrome and Addison disease-Dr.Hamisi Mkindi
Cushing syndrome and Addison disease-Dr.Hamisi MkindiCushing syndrome and Addison disease-Dr.Hamisi Mkindi
Cushing syndrome and Addison disease-Dr.Hamisi Mkindi
Mkindi Mkindi
 
Macrophage activation
Macrophage activation Macrophage activation
Macrophage activation
Maduka Sanjeewa
 
Acute Pancreatitis.pdf
Acute Pancreatitis.pdfAcute Pancreatitis.pdf
Acute Pancreatitis.pdf
baharhoseini
 
Nephrotic And Nephritic Syndrome 2008
Nephrotic And Nephritic Syndrome 2008Nephrotic And Nephritic Syndrome 2008
Nephrotic And Nephritic Syndrome 2008Dang Thanh Tuan
 
proteinuria approach Dr. Abdel Rahman Mansy.pdf
proteinuria approach Dr. Abdel Rahman Mansy.pdfproteinuria approach Dr. Abdel Rahman Mansy.pdf
Pediatrics Nephrotic and Nephritic Syndrome 7.ppt
Pediatrics Nephrotic and Nephritic Syndrome 7.pptPediatrics Nephrotic and Nephritic Syndrome 7.ppt
Pediatrics Nephrotic and Nephritic Syndrome 7.ppt
Arun170190
 
Ckd
CkdCkd
Nephrotic syndrome final shivaom
Nephrotic syndrome final shivaomNephrotic syndrome final shivaom
Nephrotic syndrome final shivaom
Shivaom Chaurasia
 
case on myocardial infarction
case on myocardial infarctioncase on myocardial infarction
case on myocardial infarction
Aiswarya Thomas
 

Similar to grand round 2.pptx (20)

Nephrotic.pptx
Nephrotic.pptxNephrotic.pptx
Nephrotic.pptx
 
Pancreatitis scm
Pancreatitis scmPancreatitis scm
Pancreatitis scm
 
23 renal disease
23 renal disease23 renal disease
23 renal disease
 
Major Case Presentation Final Version
Major Case Presentation Final VersionMajor Case Presentation Final Version
Major Case Presentation Final Version
 
Chronic renal Disease\failure (CKD)
Chronic renal Disease\failure (CKD)Chronic renal Disease\failure (CKD)
Chronic renal Disease\failure (CKD)
 
Adrenal insufficiency
Adrenal insufficiencyAdrenal insufficiency
Adrenal insufficiency
 
Management of Chronic Kidney Disorder (CKD)
Management of Chronic Kidney Disorder (CKD)Management of Chronic Kidney Disorder (CKD)
Management of Chronic Kidney Disorder (CKD)
 
1. Nephrotic syndrome 01.04.15 lecture.pptx
1. Nephrotic syndrome 01.04.15 lecture.pptx1. Nephrotic syndrome 01.04.15 lecture.pptx
1. Nephrotic syndrome 01.04.15 lecture.pptx
 
Moeez
Moeez Moeez
Moeez
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Cushing syndrome and Addison disease-Dr.Hamisi Mkindi
Cushing syndrome and Addison disease-Dr.Hamisi MkindiCushing syndrome and Addison disease-Dr.Hamisi Mkindi
Cushing syndrome and Addison disease-Dr.Hamisi Mkindi
 
Macrophage activation
Macrophage activation Macrophage activation
Macrophage activation
 
Ns
NsNs
Ns
 
Acute Pancreatitis.pdf
Acute Pancreatitis.pdfAcute Pancreatitis.pdf
Acute Pancreatitis.pdf
 
Nephrotic And Nephritic Syndrome 2008
Nephrotic And Nephritic Syndrome 2008Nephrotic And Nephritic Syndrome 2008
Nephrotic And Nephritic Syndrome 2008
 
proteinuria approach Dr. Abdel Rahman Mansy.pdf
proteinuria approach Dr. Abdel Rahman Mansy.pdfproteinuria approach Dr. Abdel Rahman Mansy.pdf
proteinuria approach Dr. Abdel Rahman Mansy.pdf
 
Pediatrics Nephrotic and Nephritic Syndrome 7.ppt
Pediatrics Nephrotic and Nephritic Syndrome 7.pptPediatrics Nephrotic and Nephritic Syndrome 7.ppt
Pediatrics Nephrotic and Nephritic Syndrome 7.ppt
 
Ckd
CkdCkd
Ckd
 
Nephrotic syndrome final shivaom
Nephrotic syndrome final shivaomNephrotic syndrome final shivaom
Nephrotic syndrome final shivaom
 
case on myocardial infarction
case on myocardial infarctioncase on myocardial infarction
case on myocardial infarction
 

More from AbdirisaqJacda1

viral infections......................ppt
viral infections......................pptviral infections......................ppt
viral infections......................ppt
AbdirisaqJacda1
 
appoach to non traumatic chest pain.pptx
appoach to non traumatic chest pain.pptxappoach to non traumatic chest pain.pptx
appoach to non traumatic chest pain.pptx
AbdirisaqJacda1
 
VTE Seminar ,,,,,,,,,,,,,,,.....................(2).pptx
VTE Seminar ,,,,,,,,,,,,,,,.....................(2).pptxVTE Seminar ,,,,,,,,,,,,,,,.....................(2).pptx
VTE Seminar ,,,,,,,,,,,,,,,.....................(2).pptx
AbdirisaqJacda1
 
appoach to non traumatic chest pain.pptx
appoach to non traumatic chest pain.pptxappoach to non traumatic chest pain.pptx
appoach to non traumatic chest pain.pptx
AbdirisaqJacda1
 
Empulse trialfdgfhgyughiyuhiyuhiyujhgjfg .pptx
Empulse trialfdgfhgyughiyuhiyuhiyujhgjfg .pptxEmpulse trialfdgfhgyughiyuhiyuhiyujhgjfg .pptx
Empulse trialfdgfhgyughiyuhiyuhiyujhgjfg .pptx
AbdirisaqJacda1
 
UPPER GIT BLEEDING.pptx
UPPER GIT BLEEDING.pptxUPPER GIT BLEEDING.pptx
UPPER GIT BLEEDING.pptx
AbdirisaqJacda1
 
ICU Care Bundles Ashenafi.pptx
ICU Care Bundles Ashenafi.pptxICU Care Bundles Ashenafi.pptx
ICU Care Bundles Ashenafi.pptx
AbdirisaqJacda1
 
cardiomyopathy2-230605222918-365b12c0.pptx
cardiomyopathy2-230605222918-365b12c0.pptxcardiomyopathy2-230605222918-365b12c0.pptx
cardiomyopathy2-230605222918-365b12c0.pptx
AbdirisaqJacda1
 
Cirrhosis and Its Complications Elfign.pptx
Cirrhosis and Its Complications Elfign.pptxCirrhosis and Its Complications Elfign.pptx
Cirrhosis and Its Complications Elfign.pptx
AbdirisaqJacda1
 
4. Pancreatic cancer.pptx
4. Pancreatic cancer.pptx4. Pancreatic cancer.pptx
4. Pancreatic cancer.pptx
AbdirisaqJacda1
 
Hypertrophic cardiomyopathy.pptx
Hypertrophic cardiomyopathy.pptxHypertrophic cardiomyopathy.pptx
Hypertrophic cardiomyopathy.pptx
AbdirisaqJacda1
 
5. Gastritis H.pptx
5. Gastritis H.pptx5. Gastritis H.pptx
5. Gastritis H.pptx
AbdirisaqJacda1
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
AbdirisaqJacda1
 
Dapa HF trial.pptx
Dapa HF trial.pptxDapa HF trial.pptx
Dapa HF trial.pptx
AbdirisaqJacda1
 
EMPA-KIDNEY.pptx
EMPA-KIDNEY.pptxEMPA-KIDNEY.pptx
EMPA-KIDNEY.pptx
AbdirisaqJacda1
 
5. Tetanus.pptx
5. Tetanus.pptx5. Tetanus.pptx
5. Tetanus.pptx
AbdirisaqJacda1
 
Grnad round.pptx
Grnad round.pptxGrnad round.pptx
Grnad round.pptx
AbdirisaqJacda1
 
ILD Seminar.pptx
ILD Seminar.pptxILD Seminar.pptx
ILD Seminar.pptx
AbdirisaqJacda1
 
copd.pptx
copd.pptxcopd.pptx
copd.pptx
AbdirisaqJacda1
 
Pulmonary Embolism.ppt
Pulmonary Embolism.pptPulmonary Embolism.ppt
Pulmonary Embolism.ppt
AbdirisaqJacda1
 

More from AbdirisaqJacda1 (20)

viral infections......................ppt
viral infections......................pptviral infections......................ppt
viral infections......................ppt
 
appoach to non traumatic chest pain.pptx
appoach to non traumatic chest pain.pptxappoach to non traumatic chest pain.pptx
appoach to non traumatic chest pain.pptx
 
VTE Seminar ,,,,,,,,,,,,,,,.....................(2).pptx
VTE Seminar ,,,,,,,,,,,,,,,.....................(2).pptxVTE Seminar ,,,,,,,,,,,,,,,.....................(2).pptx
VTE Seminar ,,,,,,,,,,,,,,,.....................(2).pptx
 
appoach to non traumatic chest pain.pptx
appoach to non traumatic chest pain.pptxappoach to non traumatic chest pain.pptx
appoach to non traumatic chest pain.pptx
 
Empulse trialfdgfhgyughiyuhiyuhiyujhgjfg .pptx
Empulse trialfdgfhgyughiyuhiyuhiyujhgjfg .pptxEmpulse trialfdgfhgyughiyuhiyuhiyujhgjfg .pptx
Empulse trialfdgfhgyughiyuhiyuhiyujhgjfg .pptx
 
UPPER GIT BLEEDING.pptx
UPPER GIT BLEEDING.pptxUPPER GIT BLEEDING.pptx
UPPER GIT BLEEDING.pptx
 
ICU Care Bundles Ashenafi.pptx
ICU Care Bundles Ashenafi.pptxICU Care Bundles Ashenafi.pptx
ICU Care Bundles Ashenafi.pptx
 
cardiomyopathy2-230605222918-365b12c0.pptx
cardiomyopathy2-230605222918-365b12c0.pptxcardiomyopathy2-230605222918-365b12c0.pptx
cardiomyopathy2-230605222918-365b12c0.pptx
 
Cirrhosis and Its Complications Elfign.pptx
Cirrhosis and Its Complications Elfign.pptxCirrhosis and Its Complications Elfign.pptx
Cirrhosis and Its Complications Elfign.pptx
 
4. Pancreatic cancer.pptx
4. Pancreatic cancer.pptx4. Pancreatic cancer.pptx
4. Pancreatic cancer.pptx
 
Hypertrophic cardiomyopathy.pptx
Hypertrophic cardiomyopathy.pptxHypertrophic cardiomyopathy.pptx
Hypertrophic cardiomyopathy.pptx
 
5. Gastritis H.pptx
5. Gastritis H.pptx5. Gastritis H.pptx
5. Gastritis H.pptx
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
Dapa HF trial.pptx
Dapa HF trial.pptxDapa HF trial.pptx
Dapa HF trial.pptx
 
EMPA-KIDNEY.pptx
EMPA-KIDNEY.pptxEMPA-KIDNEY.pptx
EMPA-KIDNEY.pptx
 
5. Tetanus.pptx
5. Tetanus.pptx5. Tetanus.pptx
5. Tetanus.pptx
 
Grnad round.pptx
Grnad round.pptxGrnad round.pptx
Grnad round.pptx
 
ILD Seminar.pptx
ILD Seminar.pptxILD Seminar.pptx
ILD Seminar.pptx
 
copd.pptx
copd.pptxcopd.pptx
copd.pptx
 
Pulmonary Embolism.ppt
Pulmonary Embolism.pptPulmonary Embolism.ppt
Pulmonary Embolism.ppt
 

Recently uploaded

POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 

Recently uploaded (20)

POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 

grand round 2.pptx

  • 1. GRAND ROUND HYPOTHYROIDISM Moderator: Samir Abdi M.D (Internist) Presenter: Abdirisak Jacda M.D (R1 IM) 8/18/2023
  • 2. Summary  Hx 20 yrs. old woman with known history of recurrent ascites  CC.. Worsened body swelling last 2 months  HPI she was having recurrent ascites body swelling for last 2 years but worsened last two 2months the swelling spread from abdomen to extremities then lastly to her face,  ROS  respiratory SOB orthopnea Cough  Neuro headache dizziness and  Cardiac palpitation anasarca  GU freq, urgency, burning, dysuria with flank pain  GI epigastric pain nausea constipation  General fatigue loss of appetite but no fever or night sweet
  • 3. Summary  Past obhx two previous NSVD with later one with PPH  Pmhx two paracentesis one therapeutic and one diagnostic  Fmhx no similar case  Social hx:- near baki district  Drug hx frusemide 40mg od po Paracetamol 500mg po PRN
  • 4. Phsyicals  Vitals BP 120/75 P. 117 O2 stat 96% T 36.5 RR 26  Day 2 vitals  BP 140/90 P. 96 O2stat 88% T 37.4 RR 22 RBG 207 FBS 124  Generally, young aged woman looking sick with profound anasarca  HEENT, severe pallor on congictiva nails and palms  neck, painless diffuse goiter mobile with swallowing
  • 5.  Cardiac:- unremarkable  Lungs:- orthopnea in day one bilateral basilar crackles with dullnes on percussion  Abdomen non-tender, distended due to gravidarum. Have also shifting dullnes with active bowel sounds  Neuro GCS of 15/15  Periphery bilateral biting edema
  • 6. Date Before admission Day 1 on admission Day 6 on admission HGB 8.6 7.7 9.1 MCV 89 86 87 PLT 361 Normal Normal doen to rule out preecalpsia Cr 1.2 0.8 0.6 BUN 49 38 32 UA WBC LE Protein Serum albumi n Numerous +++ ++++ 20g/L or 2mg/dL TSH 0.54 Recheck 0.48 T3 0.5 T4 37.5 HbsAg Positive
  • 7. Blood grouping and cross match done Revealing ORH-ve
  • 8.
  • 9.
  • 10. X-ray  Bilateral lower lobe small pleural effusion.
  • 12. Assessments 1. UTI 2. Hypothyroidism 3. AKI 4. Nephrotic syndrome 5. Chronic HBV infection PLAN • Two Units of blood given superheema 1 ampule BID • Augmentin 625mg BID • Tramadol 50mg IM PRN • Omeprazole 20mg po od • Levothyroxine 100mg po od • Dexamethasone 6mg IM BID
  • 13. Ddx ????? 1. Nephrotic syndrome 2. Preeclampsia 3. Hypothyroidism
  • 14. For nephrotic syndrome  Protein loss from kidney  3-4 gram per dipstick  Anasarca  Hypoalbuminemia Against Hypothyroid sx
  • 15. NEPHROTIC GNs  less inflammation (proliferation) than the nephritic GNs  “nephrotic” urine:  see less hematuria, more proteinuria  azotemia less common, or at least less rapid  hypertension not as common
  • 16. NEPHROTIC SYNDROME Is a syndrome, not a disease  collection of symptoms and signs due to a common pathology Can be caused by a variety of diseases Must look for the specific disease
  • 17. DEFINITION Syndrome consisting of the following:  proteinuria > 3.5 grams/24 hrs  hypoalbuminemia  hyperlipidemia and lipiduria  peripheral edema
  • 18. MECHANISM glomerular abnormality  “nephrotic” range proteinuria is initial insult  generally > 3.5 grams/24 hrs hypoalbuminemia
  • 19. HYPOALBUMINEMIA  due to  losses in urine  liver attempts to compensate by  albumin synthesis (up to 50- 60%) probably in response to  plasma oncotic pressure  general correlation between urine losses and serum levels
  • 20. MECHANISM glomerular abnormality  “nephrotic” range proteinuria is initial insult  generally > 3.5 grams/24 hrs hypoalbuminemia hyperlipidemia/lipiduria
  • 21. HYPERLIPIDEMIA  see  triglycerides, VLDL, LDL, Lp(a) in serum  see  lipid in urine in form of: free fat droplets fatty casts oval fat bodies
  • 22.
  • 23. HYPERLIPIDEMIA  vascular risk likely the same as for non- nephrotics  nephrotic pts may have 5.5x greater risk for MI  HMG CoA reductase inhibitors (“statins”) are drugs of choice
  • 24. MECHANISM glomerular abnormality  “nephrotic” range proteinuria is initial insult generally > 3.5 grams/24 hrs hyperlipidemia/lipiduria hypoalbuminemia peripheral edema (+ renal salt retention)
  • 25.  Glomerulopathy  Primary  Secondary  some glomerulopathy  can present as more than one syndrome at different times
  • 26. The Spectrum of Glomerular Pathology The Nephritic-Nephrotic Spectrum  a clinical picture anywhere on a spectrum with pure nephritic and pure nephrotic syndromes at the extremes
  • 27. Glomerular Disease: Pathogenesis  Genetic mutations  Infection  Toxin exposure  Autoimmunity  Atherosclerosis  Hypertension  Emboli  Thrombosis  Diabetes mellitus
  • 29. EDEMA HEART LIVER KIDNEY CAP LEAK urinalysis nephrotic nephritic MCD MGN FSGS DMN IgAN IgAN SLE antiGBM IC ANCA (quantitate proteinuria) LYMPH/VEINS
  • 30. OTHER COMPLICATIONS  progression to ESRF  EDEMA  infection  hypercoagulation  risk of complication correlates with degree of proteinuria  reduction of proteinuria leads to reduction in risk  if proteinuria cannot be reduced, then risk must be addressed hyperlipidemia
  • 31. NEPHROTIC SYNDROME Minimal Change Disease Membranous Glomerulonephropathy Focal Segmental Glomerulosclerosis Diabetic Nephropathy Amyloidosis
  • 33. EPIDEMIOLOGY Minimal Change Disease = kids FSGS = everyone Membranous = adults 0 yrs 65 yrs 100% 0%
  • 34. PATHOGENESIS MCD and FSGS  T cells produce abnormal cytokine that leads to glomerular epithelial cell damage  retraction of podocytes due to ?interaction with anchoring proteins  b-dystroglycan  a3-b1 integrin Membranous  due to immune complex deposition
  • 35. PATHOGENESIS Causes  most commonly idiopathic (“primary”)  90% of cases  may be secondary to:  drugs..(NSAIDs, lithium, gold)  malignancy  infections..(HIV, hepatitis B+C)
  • 36. PRESENTATION Symptoms  usually present with edema  facial, lower limb, arms/hands  often quite abrupt with MCD  otherwise well. .don’t look sick  may complain of foamy Signs  pitting edema in dependent areas  usually not much else
  • 37. INVESTIGATIONS Urine  dipstick strongly (+) for protein, little blood  usually more than 3.0g/24 hr on collection  microscopy shows lipiduria  free fat droplets  oval fat bodies  fatty casts Blood  hypoalbuminemia  hyperlipidemia  creatinine usually normal or mildly elevated
  • 38.
  • 39. DIAGNOSIS  cannot differentiate between various nephrotic GNs from history/exam alone  firm diagnosis depends on renal biopsy
  • 40. PROGNOSIS MCD MGN FSGS Persistent proteinuria 60-70% remit or stabilize persistent proteinuria Renal failure usually NOT a concern 30% chance of progression to ESRF over 15 yrs 5 yr renal survival 60-90% 10 yr renal survival 30-50%
  • 41. TREATMENT MCD  corticosteroids the drug of choice  in children, biopsy usually not done straight to steroids with nephrotic syndrome  in adults, biopsy usually done for diagnosis first  1 mg/kg daily usual dose  may require 4-8 wks. before response is seen
  • 42. TREATMENT MGN  all pts should receive angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blocking agents (ARBs)  2nd line treatment reserved for those pts at risk of progression  elevated creatinine at presentation  normal GFR after 3 yrs is good sign  proteinuria > 10g/24 hrs  esp if > 6 months duration
  • 43. TREATMENT FSGS  corticosteroids the drug of choice  2 mg/kg alternate days is usual dose  may require 3 months before response is seen (often 6-9 months for full response)  50% remission rate
  • 44. TREATMENT 3 main 2nd line agents include  corticosteroids  variable results when used alone  best used in combination with another agent  cyclophosphamide  probably more effective than steroids alone but higher toxicity  cyclosporine  may also be useful as first line…usually less toxicity
  • 45. MGN and FSGS Recommendations  asymptomatic, protein < 3.5 g/day  ACEi/ARB  asymptomatic, protein > 3.5 g/day and no risk factors  ACEi/ARB  symptomatic, protein > 3.5 g/day  ACEi/ARB + 2nd line agent  asymptomatic, protein > 3.5 g/day + risk factors  ACEi/ARB + 2nd line agent
  • 46. TREATMENT MCD MGN FSGS corticosteroids (prednisone)  30%  2ND line agents rarely 30% 50% plasmapheresis 10% (post transplant)
  • 47. TAKE HOME MESSAGE  some glomerular diseases present with a “nephrotic” picture  proteinuria, edema, hyperlipidemia, hypoalbuminemia  thrombosis, infection  these diseases may progress to ESRF but usually very slowly  renal Bx is usually the only way to make a firm diagnosis
  • 49. For hypothyroidism  Sx  edema constipation fatigue  Signs  loss of outer 1/3 of eyebrows  Congestion abdominal distension shifting dullnes, bibasilar carckles bitting edema till knees  Labs low T3/T4 and low TSH Against  Labs  proteinuria  Hypoalbuminemia
  • 50. Classification of Hypothyroidism www.drsarma.in 50 A. Primary 1. Enlarged Thyroid - Hashimoto’s (65%) - Iodine Deficiency (25%) - Drug-induced (Lithium) - Dysharmonogenesis 2. Normal Thyroid - Spontaneous Atrophic Primary contd.. 3. Post Ablative - Permanent - Transient - Sub-clinical 4. Congenital B. Secondary / Central Pituitary/ hypothalamic
  • 53. www.drsarma.in 53 Disease Burden 1. 5% of the general population are Sub-clinically Hypothyroid 2. 15 % of all women > 65 yrs. are hypothyroid 3. Detecting sub-clinical hypothyroidism in pregnancy is highly essential – order for TSH and FT4 routinely in all pregnant women at the beginning of each trimester 4. All persons aged above 60 years – Order for TSH
  • 54. www.drsarma.in 54 Multi system effects - Hypothyroidism General •Lethargy, Somnalence •Weight gain, Goitre •Cold Intolerence Cardiovascular •Bradycardia, Angina •CHF, Pericardial Effusion •HyperlipIdemia, Xanthelsma Haematological Iron def. Anaemia, Normo cytic /chromic Anaemia Reproductive system •Infertility, Menorrhagia •Impotence, Inc. Prolactin Neuromuscular •Aches and pains •Muscle stiffness •Carpel tunnel syndrome •Deafness, Hoarseness •Cerebellar ataxia •Delayed DTR, Myotonia •Depression, Psychosis Gastro-intestinal •Constipation, Ileus, Ascites Dermatological •Dry flaky skin and hair •Myxoedema, Malar flushes •Vitiligo, Carotenimia,
  • 55. www.drsarma.in 55 Clinical Signs of Hypothyroidism  Coarse Hair; Dry cool and pale skin  Goitre (not in all cases), Hoarseness of voice  Non-pitting oedema (myxoedema)  Puffiness of eyes and face  Delayed relaxation of DTR  Slow hoarse speech and slow movements  Thinning of lateral 1/3 of eye brows  Bradycardia, pericardial effusion
  • 56. What the mind knows the eyes see !! www.drsarma.in 56  Psychiatric patients  Elderly women / men  Patients of OSA  Hypercholesterolemia  Lithium, Amiodarone  Postpartum women  Other Autoimmune disease  Rx. Grave’s Ophthalmopathy  Family H/o thyroid disease  Neck irradiation therapy  Previous Rx for thyrotoxicosis  Autoimmune Thyroiditis Order for TSH alone as a screen
  • 67. www.drsarma.in 67 Clearing of Pericardial Effusion with Rx. 26.7.98
  • 68. www.drsarma.in 68 Reappearance of Pericardial Effusion after treatment is discontinued 14.9.99
  • 70. Many Causes, One Treatment www.drsarma.in 70  Normalize TSH level regardless of cause of hypothyroidism  Once daily dosing with Levothyroxine sodium (1.6µg/kg/day) this comes to 100 mcg per day  Monitor TSH level at 6 to 8 weeks, after initiation of therapy or dosage change
  • 71. www.drsarma.in 71 • Treatment of choice is levothyroxin • Branded thyroxine recommended • No divided doses - illogical • Not recommended for use :  Desiccated thyroid extract  Combination of thyroid hormones  T3 replacement except in Myxedema coma Many Causes, One Treatment
  • 72. www.drsarma.in 72  Age (in elderly start with half dose)  Severity and duration of hypothyroidism (↑ dose)  Weight (0.5µg/kg/day ↑ upto 3.0µg/kg/day)  Malabsorption (requires ↑ dose)  Concomitant drug therapy (only on empty stomach)  Pregnancy ( 25% ↑ in dose), safe in lactating mother  Presence of cardiac disease (start alternate day Rx) Dosage Adjustments
  • 73. www.drsarma.in 73  Goal : normalize TSH level – 25, 50 and 100 mcg tablets avail.  Starting dose for healthy patients < 50 years at 1.0 µg/kg/day  Starting dose for healthy patients > 50 years should be < 50 µg/day. Dose ↑ by 25 µg, if needed, at 6 to 8 weeks intervals.  Starting dose for patients with heart disease should be 12.5 to 25 µg/day and increase by 12.5 to 25 µg/day, if needed, at 6 to 8 weeks intervals Start Low and Go Slow
  • 74. www.drsarma.in 74 How the patient improves  Feels better in 2 – 3 weeks  Reduction in weight is the first improvement ???????????????????  Facial puffiness then starts coming down  Skin changes, hair changes take long time to regress  TSH starts showing decrements from the high values  TSH returns to normal eventually
  • 76. 76 The Commandments  Highly suspect hypothyroidism  Growth and pubertal delay  Unexplained depression  TSH is the test in Hypothy.  TSH, FT4 to confirm Dx.  Nine square magic  Test cord blood for TSH  All obese patients TSH a must  For all pregnant -test TSH, FT4  Postmenopausal 15% Hypothy  Start low and go slow  Use Levothyroxine only  Always on empty stomach  Thyroxine - avoid empirical use
  • 77. www.drsarma.in 77 • Case Report • A 60years old male patient presented with symptoms of insidious onset, painless, progressive abdominal distension since 2 months and progressive swelling of both lower limbs since 1 month. • He also had constipation and progressive hoarseness of voice for 2 months. • He had no history of chest pain, shortness of breath, orthopnea, paroxysmal nocturnal dyspnea, jaundice, abdominal pain, hematemesis, melena, urinary symptoms, anorexia or weight loss. • He was a chronic smoker for last 25 years and non- alcoholic.
  • 78. www.drsarma.in 78 • Examination revealed mild periorbital and facial puffiness along with bilateral pitting pedal edema. • His skin was dry and coarse. • Neurological examination revealed delayed relaxation of ankle jerks. • The patient was afebrile with a pulse rate of 75/min, blood pressure 130/80 mm of Hg and elevated jugular venous pressure. • On cardiopulmonary examination there was muffled heart sounds with absent breath sounds. • Chest radiograph showed massive cardiomegaly with bilateral pleural effusion. • Ultrasonography abdomen showed moderate ascites and computed tomography chest and abdomen revealed massive pericardial effusion, bilateral pleural effusion and moderate ascites.
  • 79. www.drsarma.in 79 • Electrocardiogram showed low voltage QRS complexes . • 2D Echocardiogram done subsequently showed a large circumferential echo free space consistent with massive pericardial effusion and evidence of cardiac tamponade (diastolic collapse of right atrium and right ventricle free wall) with preserved left ventricular systolic function, ejection fraction 55%. • Viral serology for both hepatitis B and C were negative, • UGI endoscopy and colour doppler of abdomen were done to rule out portal hypertension and both were normal.
  • 80. www.drsarma.in 80  Ascitic fluid study showed total cells of 100/ cumm with 98% lymphocytes, high protein (3.24 gm%) and high serum ascitic albumin gradient (SAAG - 1.91) and normal adenosine deaminase level (ADA - 6.8 U/L) .  Pleural fluid examination showed total cells of 200 / cumm with 90% lymphocytes, high protein (3 . 97 gm%), normal sugar and normal ADA level (8.1 U/L).  Cytology of both the fluids were negative for malignancy.  In view of cardiac tamponade, pericardiocentesis was done with aspiration of about 1500 ml straw colour fluid.  Analysis of fluid showed total cells of 10 /cumm with high protein (5.3 gm%), normal ADA level (8.3 U/L), and cytology revealed mainly lymphoid and degenerated cells but no malignant cells.  Culture of the pericardial fluid was negative for bacteria and acid
  • 81. www.drsarma.in 81  Thyroid function tests showed TSH 137.8 mIU/ml (normal range 0.4 – 4), free T4 0.45 ng/dl (normal range 0.89  – 1.76), and free T3 0.63 pg/ml (normal range 0.92 – 2.78).  Ultrasonography revealed atrophic changes in both thyroid lobes. TPO antibody was negative.  Subsequent hospital course was uncomplicated and he was discharged with gradually escalating dose of levothyroxine from 50 to 100 microgram daily.  On 4 weeks follow up he was in good health and had abatement of ascites, pleural effusion and tissue edema and only minimal pericardial effusion left.  His TSH was 30.1m IU/ ml and he continued on a maintenance dose of 100 microgram with regular follow up.
  • 82. www.drsarma.in 82  The recent studies, however, conclude that PE is extremely infrequent in hypothyroidism, with an incidence of 3% to 6%.  The mainstay of treatment for thyroid PE is simple thyroxine replacement, except in those patients w i t h pericardial tamponade or impending tamponade, this condition mandates urgent pericardiocentesis.  Pleural effusion per se due to hypothyroidism is rare and requires careful exclusion of other associated conditions.  Effusions solely due to hypothyroidism have borderline characteristics between exudates and transudates and show little evidence of inflammation.
  • 83. www.drsarma.in 83  In conclusion hypothyroidism can have rare modes of presentations  .  It can present with either isolated effusion or in combination of multiple body cavity effusions along with tissue edema.  High index of clinical suspicion is required to diagnose such cases.  The treatment is simple and gratifying with almost complete regression of findings after thyroid hormone
  • 84. pre-eclampsia  Summary brief summary  And ddx with treatment and referral to obstetrician of maternity ward
  • 85. For pre-eclampsia  Proteinuria  Generalized edema  Hypo-albuminemia Against Goiter Normotensive Normal liver enzymes Normal platelet count

Editor's Notes

  1. Spectrum of glomerular diseases. At one extreme, specific injury to podocytes or structural alteration of the glomerulus affecting podocyte function (for example, by scarring or deposition of excess matrix or other material) causes proteinuria and nephrotic syndrome (see Box 17.11 , p. 475). The histology to the left shows diabetic nephropathy. At the other end of the spectrum, inflmmation leads to cell damage and proliferation, breaks form in the GBM and blood leaks into urine. In its extreme form, with acute sodium retention and hypertension, such disease is labelled nephritic syndrome. The histology to the right shows a glomerulus with many extra nuclei from proliferating intrinsic cells, and inflx of inflmmatory cells shows crescent formation (arrows) in response to severe post-infectious glomerulonephritis. (FSGS = focal and segmental glomerulosclerosis; MCGN = mesangiocapillary glomerulonephritis)